The Handoff: Your Week in Neurology News - 1/19/17

UCB Pharma looks to expand its epilepsy drug as Biogen cuts a deal to protect Tecfidera, while insiders suggest that pharmacists should play a bigger role in managing the growing Alzheimer's dementia population.

The Handoff: Your Week in Neurology News - 1/12/17

The medical community questions whether mobile stroke units are sustainable, new research further links concussions with Alzheimer's disease, and a new trial examines the effects of fasting on MS.

The Handoff: Your Week in Neurology News - 1/5/17

Happy New Year! Reflect on some of 2016's greatest neurological advances and look forward as institutions like the NIH take on a focused effort to explore new drugs for rare disease, the developing brain, and more.

The Handoff: Your Week in Neurology News - 12/22/16

The FDA has delayed the decision on ocrelizumab after manufacturing issues arise, while it gives the thumbs up to an investigational treatment for complex regional pain syndrome.

The Handoff: Your Week in Neurology News - 12/15/16

The NCAA honored the man and ALS patient behind the viral ALS Ice Bucket Challenge, while the UK approved mitochondrial replacement reproductive assistance and Bristol-Myers Squibb faces a $20 million fine for promoting off-label uses of its antipsychotic Abilify.

The Handoff: Your Week in Neurology News - 12/8/16

The Handoff: Your Week in Neurology News - 12/8/16

The Handoff: Your Week in Neurology News - 12/1/16

While Alzheimer's research may have hit a speed bump, research exploring gender differences in concussion and controversial treatments for autism and PTSD, including MDMA, are moving full-steam ahead.

The Handoff: Your Week in Neurology News - 11/17/16

As the neurology world awaits study results from the solanezumab trial, Boston Medical Center is investing in telehealth for epilepsy care and US prisons are administering a questionable $1,000-a-month injection for opioid addiction.

The Handoff: Your Week in Neurology News - 11/10/16

The Handoff: Your Week in Neurology News - 11/10/16

The Handoff: Your Week in Neurology News - 11/3/16

More lessons from the eteplirsen controversy, a biologic-based assessment for addiction disorders, a virtual, hassle-free trial for a potential ALS treatment, and more.

Sign Up for Free e-newsletters